Report Detail
Global (United States, European Union and China) Lou Gehrigs Disease Market Research Report 2019-2025
- RnM3695657 |
- 26 August, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.
In 2019, the market size of Lou Gehrigs Disease is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Lou Gehrigs Disease.
This report studies the global market size of Lou Gehrigs Disease, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Lou Gehrigs Disease sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AB Science
Avicena Group
Biogen
BrainStorm Therapeutics
Covis Pharmaceutical Inc.
Cytokinetics Inc.
Eisai Co. Ltd.
GlaxoSmithKline plc.
Ionis Pharmaceuticals, Inc.
Mitsubishi Tanabe Pharma Corp.
Neuralstem Inc.
Neuraltus Pharmaceuticals Inc.
Newron Pharmaceuticals S.p.A.
Nutra Pharma Corp.
Pharnext SAS
Q-Therapeutics Inc.
Market Segment by Product Type
Riluzole
Edaravone (Radicava)
Market Segment by Application
Hospital Pharmacies
Retail & Online Pharmacie
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Lou Gehrigs Disease status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Lou Gehrigs Disease manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Lou Gehrigs Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Lou Gehrigs Disease Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Riluzole
- 1.3.3 Edaravone (Radicava)
- 1.4 Market Segment by Application
- 1.4.1 Global Lou Gehrigs Disease Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail & Online Pharmacie
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Lou Gehrigs Disease Market Size
- 2.1.1 Global Lou Gehrigs Disease Revenue 2014-2025
- 2.1.2 Global Lou Gehrigs Disease Sales 2014-2025
- 2.2 Lou Gehrigs Disease Growth Rate by Regions
- 2.2.1 Global Lou Gehrigs Disease Sales by Regions 2014-2019
- 2.2.2 Global Lou Gehrigs Disease Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Lou Gehrigs Disease Sales by Manufacturers
- 3.1.1 Lou Gehrigs Disease Sales by Manufacturers 2014-2019
- 3.1.2 Lou Gehrigs Disease Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Lou Gehrigs Disease Revenue by Manufacturers (2014-2019)
- 3.2.2 Lou Gehrigs Disease Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Lou Gehrigs Disease Market Concentration Ratio (CR5 and HHI)
- 3.3 Lou Gehrigs Disease Price by Manufacturers
- 3.4 Key Manufacturers Lou Gehrigs Disease Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Lou Gehrigs Disease Market
- 3.6 Key Manufacturers Lou Gehrigs Disease Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Riluzole Sales and Revenue (2014-2019)
- 4.1.2 Edaravone (Radicava) Sales and Revenue (2014-2019)
- 4.2 Global Lou Gehrigs Disease Sales Market Share by Type
- 4.3 Global Lou Gehrigs Disease Revenue Market Share by Type
- 4.4 Lou Gehrigs Disease Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Lou Gehrigs Disease Sales by Application
6 United States
- 6.1 United States Lou Gehrigs Disease Breakdown Data by Company
- 6.2 United States Lou Gehrigs Disease Breakdown Data by Type
- 6.3 United States Lou Gehrigs Disease Breakdown Data by Application
7 European Union
- 7.1 European Union Lou Gehrigs Disease Breakdown Data by Company
- 7.2 European Union Lou Gehrigs Disease Breakdown Data by Type
- 7.3 European Union Lou Gehrigs Disease Breakdown Data by Application
8 China
- 8.1 China Lou Gehrigs Disease Breakdown Data by Company
- 8.2 China Lou Gehrigs Disease Breakdown Data by Type
- 8.3 China Lou Gehrigs Disease Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Lou Gehrigs Disease Breakdown Data by Company
- 9.2 Rest of World Lou Gehrigs Disease Breakdown Data by Type
- 9.3 Rest of World Lou Gehrigs Disease Breakdown Data by Application
- 9.4 Rest of World Lou Gehrigs Disease Breakdown Data by Countries
- 9.4.1 Rest of World Lou Gehrigs Disease Sales by Countries
- 9.4.2 Rest of World Lou Gehrigs Disease Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AB Science
- 10.1.1 AB Science Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.1.4 Lou Gehrigs Disease Product Introduction
- 10.1.5 AB Science Recent Development
- 10.2 Avicena Group
- 10.2.1 Avicena Group Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.2.4 Lou Gehrigs Disease Product Introduction
- 10.2.5 Avicena Group Recent Development
- 10.3 Biogen
- 10.3.1 Biogen Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.3.4 Lou Gehrigs Disease Product Introduction
- 10.3.5 Biogen Recent Development
- 10.4 BrainStorm Therapeutics
- 10.4.1 BrainStorm Therapeutics Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.4.4 Lou Gehrigs Disease Product Introduction
- 10.4.5 BrainStorm Therapeutics Recent Development
- 10.5 Covis Pharmaceutical Inc.
- 10.5.1 Covis Pharmaceutical Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.5.4 Lou Gehrigs Disease Product Introduction
- 10.5.5 Covis Pharmaceutical Inc. Recent Development
- 10.6 Cytokinetics Inc.
- 10.6.1 Cytokinetics Inc. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.6.4 Lou Gehrigs Disease Product Introduction
- 10.6.5 Cytokinetics Inc. Recent Development
- 10.7 Eisai Co. Ltd.
- 10.7.1 Eisai Co. Ltd. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.7.4 Lou Gehrigs Disease Product Introduction
- 10.7.5 Eisai Co. Ltd. Recent Development
- 10.8 GlaxoSmithKline plc.
- 10.8.1 GlaxoSmithKline plc. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.8.4 Lou Gehrigs Disease Product Introduction
- 10.8.5 GlaxoSmithKline plc. Recent Development
- 10.9 Ionis Pharmaceuticals, Inc.
- 10.9.1 Ionis Pharmaceuticals, Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.9.4 Lou Gehrigs Disease Product Introduction
- 10.9.5 Ionis Pharmaceuticals, Inc. Recent Development
- 10.10 Mitsubishi Tanabe Pharma Corp.
- 10.10.1 Mitsubishi Tanabe Pharma Corp. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Lou Gehrigs Disease
- 10.10.4 Lou Gehrigs Disease Product Introduction
- 10.10.5 Mitsubishi Tanabe Pharma Corp. Recent Development
- 10.11 Neuralstem Inc.
- 10.12 Neuraltus Pharmaceuticals Inc.
- 10.13 Newron Pharmaceuticals S.p.A.
- 10.14 Nutra Pharma Corp.
- 10.15 Pharnext SAS
- 10.16 Q-Therapeutics Inc.
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Lou Gehrigs Disease Sales Channels
- 11.2.2 Lou Gehrigs Disease Distributors
- 11.3 Lou Gehrigs Disease Customers
12 Market Forecast
- 12.1 Global Lou Gehrigs Disease Sales and Revenue Forecast 2019-2025
- 12.2 Global Lou Gehrigs Disease Sales Forecast by Type
- 12.3 Global Lou Gehrigs Disease Sales Forecast by Application
- 12.4 Lou Gehrigs Disease Forecast by Regions
- 12.4.1 Global Lou Gehrigs Disease Sales Forecast by Regions 2019-2025
- 12.4.2 Global Lou Gehrigs Disease Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Lou Gehrigs Disease. Industry analysis & Market Report on Lou Gehrigs Disease is a syndicated market report, published as Global (United States, European Union and China) Lou Gehrigs Disease Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Lou Gehrigs Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
